About Angelini Pharma
Angelini Pharma is a company based in Rome (Italy) founded in 1919 was acquired by AFT Pharmaceuticals in January 2017. Angelini Pharma has completed 2 acquisitions, including Arvelle Therapeutics and CatalystPharma. Angelini Pharma offers products and services including Tantum Verde, Latuda, Acutil, and ThermaCare. Angelini Pharma operates in a competitive market with competitors including Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
- Headquarter Rome, Italy
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Angelini Pharma S.P.A.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Arvelle Therapeutics
& 1 more
-
Acquired by
AFT Pharmaceuticals
(Jan 09, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Angelini Pharma
Angelini Pharma offers a comprehensive portfolio of products and services, including Tantum Verde, Latuda, Acutil, and ThermaCare.
Sore throat treatment for consumer use.
Medication for bipolar disorder management.
Support for cognitive health functions.
Heat therapy for muscle strain relief.
People of Angelini Pharma
Unlock access to complete
Funding Insights of Angelini Pharma
Detailed funding history for Angelini Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Angelini Pharma
Angelini Pharma has secured backing from 1 investor. Prominent investors backing the company include AFT Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Proprietary and in-licensed pharmaceutical products are developed and distributed.
|
Locked | Locked | Locked |
Investor details for Angelini Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Angelini Pharma
Angelini Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Arvelle Therapeutics and CatalystPharma.
Investment portfolio details for Angelini Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small molecule therapies are developed for partial-onset seizures treatment.
|
Locked | Locked | 2019 | Locked | |
|
Therapies for rare neuromuscular and neurological diseases are developed.
|
Locked | Locked | 2002 | Locked |
Complete acquisition details for Angelini Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Angelini Pharma
Detailed financials for Angelini Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Angelini Pharma Comparisons
Peer comparison for Angelini Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Angelini Pharma
Angelini Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, AbbVie, Lilly, Roche and Novo Nordisk, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| Locked | Locked | Locked |
Drugs for diabetes, obesity, hemophilia, and hormone therapy are manufactured.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
Detailed competitors of Angelini Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Angelini Pharma
Complete news archive for Angelini Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Angelini Pharma
Angelini Pharma was founded in 1919.
Angelini Pharma is headquartered in Rome, Italy. It is registered at Rome, Lazio, Italy.
Jacopo Andreose is the current CEO of Angelini Pharma.
Angelini Pharma is engaged in the manufacturing and marketing of active ingredients, branded drugs, medical products, dietary supplements, and personal hygiene products. The company markets prescription and OTC products in diverse therapeutic areas: analgesia and inflammation, neuropsychiatry, gynecology and infectious diseases. Some of its known brands are Trittico (trazodone), Tantum (benzydamine) and Aulin (nimesulide). The company is selling its supplements under BodySpring and Acutil brand names. The company has three manufacturing plants located in Ancona for finished products, Aprilia for pharmaceutical raw materials, and Casella for the production of Amuchina brand disinfectants.
Angelini Pharma's top competitors include Merck, Roivant Sciences and Amgen.
Angelini Pharma offers Tantum Verde, Latuda, Acutil, and ThermaCare.
Angelini Pharma has made 2 acquisitions, including Arvelle Therapeutics, and CatalystPharma.
Angelini Pharma has 1 investor. Key investors include AFT Pharmaceuticals.